Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based biotechnology company NeoStem has acquired Stem Cell Technologies, a wholly owned subsidiary of Utek, in a stock-for-stock transaction.
Subscribe to our email newsletter
Stem Cell Technologies owns a worldwide exclusive license to a technology developed by researchers at the University of Louisville to identify and isolate rare stem cells from adult human bone marrow, called VSELs (very small embryonic-like) stem cells.
Concurrent with the Stem Cell Technologies acquisition, NeoStem entered into a sponsored research agreement with the University of Louisville under which NeoStem will support further research in the University of Louisville laboratory, a portion of which will be covered by the acquisition.
Robin Smith, CEO of NeoStem, said: “The potential exists for the isolated VSELs to differentiate into specified cells that could be given to a patient where they would interact within the specific organ in order to repair degenerated, damaged or diseased tissue, the three ‘D’s of aging’. NeoStem is enthusiastic about this technology and its potential to help expand our proprietary position in the adult stem cell collection and storage arena as well as the burgeoning field of regenerative medicine.”